IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation

A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice

(2010) M. Hayashi et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice

(2010) Jean Pierre S. Peron et al.   JOURNAL OF NEUROIMMUNOLOGY

Increased serum IL-17 is an independent risk factor for severe asthma

(2010) Ioana Agache et al.   RESPIRATORY MEDICINE

IL-17 Eliminates the Therapeutic Effects of Myelin Basic Protein-Induced Nasal Tolerance in Experimental Autoimmune Encephalomyelitis by Activating IL-6

(2010) G.-Y. Wang et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Allergic Sensitization through the Airway Primes Th17-dependent Neutrophilia and Airway Hyperresponsiveness

(2009) Rhonda H. Wilson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

IL-23 and Th17 Cells Enhance Th2-Cell–mediated Eosinophilic Airway Inflammation in Mice

(2008) Hidefumi Wakashin et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells

(2008) T. Korn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells

(2008) Noriko M. Tsuji et al.   TRENDS IN IMMUNOLOGY